Results 271 to 280 of about 50,213 (312)

21420. USO DE ANTICUERPOS MONOCLONALES DIRIGIDOS CONTRA EL CGRP COMO TRATAMIENTO PREVENTIVO EN MENORES DE 18 AÑOS DE EDAD CON MIGRAÑA

open access: gold
Alejandro Vallejo   +9 more
openalex   +1 more source

The roles of the nerve-immune axis in modulating bone regeneration. [PDF]

open access: yesBone Res
Zhao Y   +9 more
europepmc   +1 more source

CGRP receptors: beyond the CGRP1–CGRP2 subdivision?

Trends in Pharmacological Sciences, 2001
In a recent TiPS article 1xThe molecular pharmacology of CGRP and related peptide receptor subtypes. Juaneda, C. et al. Trends Pharmacol. Sci. 2000; 21: 432–438Abstract | Full Text | Full Text PDF | PubMed | Scopus (131)See all References1, Juaneda and colleagues reviewed the molecular pharmacology of calcitonin gene-related peptide (CGRP) and related ...
D, Poyner, I, Marshall
openaire   +2 more sources

CGRP antagonists: unravelling the role of CGRP in migraine

Trends in Pharmacological Sciences, 2007
Migraine is a complex, debilitating neurovascular disorder. Although knowledge on the main molecular players is still incomplete, recent preclinical and clinical findings indicate that there is a clear correlation between migraine-associated headache and the release of the neuropeptide calcitonin gene-related peptide (CGRP). BIBN4096 was the first CGRP
Henri, Doods   +3 more
openaire   +2 more sources

Pain pharmacology in migraine: focus on CGRP and CGRP receptors

Neurological Sciences, 2007
Over the last 100 years, the discovery of new analgesics has been a complex and difficult task. However, remarkable progress in the identification of novel molecular targets relevant for pain medicines has been reported. Here we will focus on the neuropeptide calcitonin generelated peptide (CGRP) and its receptors (CGRP-R) because of their role in ...
BENEMEI, SILVIA   +3 more
openaire   +3 more sources

CGRP and its receptors

Headache: The Journal of Head and Face Pain, 2017
The calcitonin gene‐related peptide (CGRP) neuropeptide system is an important but still evolving target for migraine. A fundamental consideration for all of the current drugs in clinical trials and for ongoing development in this area is the identity, expression pattern, and function of CGRP receptors because this knowledge ...
Debbie L. Hay, Christopher S. Walker
openaire   +2 more sources

Home - About - Disclaimer - Privacy